A company developing Spiroligomers™, a new type of synthetic therapeutic molecules, secures a winning spot in the 2025 Top Innovations contest Emerging Startup category. Summary A company specializing in Spiroligomers™, a novel class of Read More
Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer Summary Pancreatic cancer often resists immunotherapy, and this resistance is linked to elevated levels of spermine, a polyamine involved in cell growth and survival. Researchers Read More
Antimicrobial resistance (AMR) towards medicine has been an ongoing concern for the last several decades. The concept that a microbe can build resistance a Summary Antimicrobial resistance (AMR) is a long-standing global health threat, where Read More
1 Million+ Views and Counting..!
It has been 7 years since it was launched in late July 2018, and it is moving forward. Appreciate all the respected visitors! Please share this site with your friends to push science forward and improve human health.
